Published online before print May 9, 2002, doi: 10.1161/01.RES.0000021127.83364.7D
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 27, 2001
Revised on April 26, 2002
Accepted on April 26, 2002
Insulin-Like Growth Factor-1 Enhances Inflammatory Responses in Endothelial Cells. Role of Gab1 and MEKK3 in TNF-
--Induced c-Jun and NF-
B Activation and Adhesion Molecule Expression
Wenyi Che ;
From the Center for Cardiovascular Research, University of Rochester, Rochester, NY, and The Scripps Research Institute (J.-D.L.), La Jolla, Calif.
* To whom correspondence should be addressed. E-mail: jun-chi_abe{at}urmc.rochester.edu.
Insulin-like growth factor (IGF)-1 and the type I IGF-1 receptor are important regulators of vascular function that may contribute to cardiovascular disease. We hypothesized that IGF-1 causes endothelial cell dysfunction and expression of neutrophil and monocyte adhesion molecules by enhancing pro-inflammatory cytokine signal transduction. Chronic IGF-1 treatment of endothelial cells potentiated c-Jun and nuclear factor (NF)-B activation by tumor necrosis factor (TNF)- and enhanced TNF---mediated adhesion molecule expression. In response to IGF-1 treatment, the expression of kinases in the c-Jun/c-Jun NH2-terminal kinase signaling pathway (MEKK1, MEK4, and JNK1/2) was unchanged, but expressions of insulin receptor substrate-1 and Grb2-associated binder-1 (Gab1) were significantly decreased. Because Gab1 is involved in both c-Jun and NF-B activation by TNF-, we focused on Gab1-dependent signaling. Gab1 inhibited c-Jun and NF-B transcriptional activation by TNF-. Interestingly, Gab1 inhibited c-Jun transcriptional activity induced by MEKK3 but not MEKK1 and MEK4. Gab1 associated with MEKK3, and a catalytically inactive form of MEKK3 inhibited TNF---induced c-Jun and NF-B transcriptional activation, suggesting a critical role for Gab1 and MEKK3 in TNF- signaling. These data demonstrate that Gab1 and MEKK3 play important roles in endothelial cell inflammation via regulating the activation of c-Jun and NF-B. Furthermore, the IGF-1--mediated downregulation of Gab1 expression represents a novel mechanism to promote vascular inflammation and atherosclerosis.
Key words: insulin-like growth factor-1 • signal transduction • Grb2-associated binder-1 • tumor necrosis factor-
•
vascular inflammation
This article has been cited by other articles:
 |
|
 |
|
  Md. R. Abid, R. J. Nadeau, K. C. Spokes, T. Minami, D. Li, S.-C. Shih, and W. C. Aird Hepatocyte Growth Factor Inhibits VEGF-Forkhead-Dependent Gene Expression in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 2042 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sukhanov, Y. Higashi, S.-Y. Shai, C. Vaughn, J. Mohler, Y. Li, Y.-H. Song, J. Titterington, and P. Delafontaine IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atherosclerosis Progression in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2684 - 2690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Bae, L. Yang, C. Manithody, and A. R. Rezaie Engineering a Disulfide Bond to Stabilize the Calcium-binding Loop of Activated Protein C Eliminates Its Anticoagulant but Not Its Protective Signaling Properties J. Biol. Chem., March 23, 2007; 282(12): 9251 - 9259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lin, Q. Yang, X. Wang, and Z.-g. Liu The Essential Role of the Death Domain Kinase Receptor-interacting Protein in Insulin Growth Factor-I-induced c-Jun N-terminal Kinase Activation J. Biol. Chem., August 18, 2006; 281(33): 23525 - 23532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bjorndahl, R. Cao, L. J. Nissen, S. Clasper, L. A. Johnson, Y. Xue, Z. Zhou, D. Jackson, A. Jon Hansen, and Y. Cao Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo PNAS, October 25, 2005; 102(43): 15593 - 15598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-K. Min, Y.-M. Lee, J. H. Kim, Y.-M. Kim, S. W. Kim, S.-Y. Lee, Y. S. Gho, G. T. Oh, and Y.-G. Kwon Hepatocyte Growth Factor Suppresses Vascular Endothelial Growth Factor-Induced Expression of Endothelial ICAM-1 and VCAM-1 by Inhibiting the Nuclear Factor-{kappa}B Pathway Circ. Res., February 18, 2005; 96(3): 300 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q.-P. Qin, S. Kokkala, J. Lund, N. Tamm, L.-M. Voipio-Pulkki, and K. Pettersson Molecular Distinction of Circulating Pregnancy-Associated Plasma Protein A in Myocardial Infarction and Pregnancy Clin. Chem., January 1, 2005; 51(1): 75 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Miceli, A. Tropea, F. Minici, M. Orlando, G. Lamanna, M. F. Gangale, B. Panetta, F. Tiberi, S. Vaccari, R. Canipari, et al. Effects of Insulin-Like Growth Factor I and II on Prostaglandin Synthesis and Plasminogen Activator Activity in Human Umbilical Vein Endothelial Cells J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 372 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Akaike, W. Che, N.-L. Marmarosh, S. Ohta, M. Osawa, B. Ding, B. C. Berk, C. Yan, and J.-i. Abe The Hinge-Helix 1 Region of Peroxisome Proliferator-Activated Receptor {gamma}1 (PPAR{gamma}1) Mediates Interaction with Extracellular Signal-Regulated Kinase 5 and PPAR{gamma}1 Transcriptional Activation: Involvement in Flow-Induced PPAR{gamma} Activation in Endothelial Cells Mol. Cell. Biol., October 1, 2004; 24(19): 8691 - 8704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kooijman and A. Coppens Insulin-like growth factor-I stimulates IL-10 production in human T cells J. Leukoc. Biol., October 1, 2004; 76(4): 862 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Conti, F. Andreotti, C. Zuppi, J. Lund, T. Ilva, P. Porela, Q.-P. Qin, K. Pettersson, L.-M. Voipio-Pulkki, and K. Pulkki Pregnancy-Associated Plasma Protein A as Predictor of Outcome in Patients With Suspected Acute Coronary Syndromes * Response Circulation, May 11, 2004; 109(18): e211 - e212. [Full Text] [PDF]
|
|
|
|
|
|
P. Delafontaine, Y.-H. Song, and Y. Li Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 435 - 444. [Abstract] [Full Text]
|
|
|
|
|
|
T. K. Hansen, S. Fisker, R. Dall, T. Ledet, J. O. L. Jorgensen, and L. M. Rasmussen Growth Hormone Increases Vascular Cell Adhesion Molecule 1 Expression: in Vivo and in Vitro Evidence J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 909 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Kapoor, Y. Zhan, G. R. Johnson, and D. M. O'Rourke Distinct Domains in the SHP-2 Phosphatase Differentially Regulate Epidermal Growth Factor Receptor/NF-{kappa}B Activation through Gab1 in Glioblastoma Cells Mol. Cell. Biol., January 15, 2004; 24(2): 823 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. I. Anderson, D. Rahmutula, and D. G. Gardner Tumor Necrosis Factor-{alpha} Inhibits Endothelial Nitric-oxide Synthase Gene Promoter Activity in Bovine Aortic Endothelial Cells J. Biol. Chem., January 9, 2004; 279(2): 963 - 969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lerner-Marmarosh, M. Yoshizumi, W. Che, J. Surapisitchat, H. Kawakatsu, M. Akaike, B. Ding, Q. Huang, C. Yan, B. C. Berk, et al. Inhibition of Tumor Necrosis Factor-{alpha}-Induced SHP-2 Phosphatase Activity by Shear Stress: A Mechanism to Reduce Endothelial Inflammation Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1775 - 1781. [Abstract] [Full Text] [PDF]
|
|